The Anti-fungal Effect of Miconazol Versus Miconazol-Loaded Chitosan Nanoparticles

NCT06072716 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2023-10-10

No results posted yet for this study

Summary

Objective: this study aimed to evaluate the therapeutic effects of topical application of miconazole and miconazole-loaded chitosan nanoparticles in treatment diabetic patients with oral candidiasis.

Conditions

  • Oral Thrush

Interventions

DRUG

Chitosan

chitosan loaded with miconazole nanoparticles gel

Sponsors & Collaborators

  • Yasmine gamil

    lead OTHER

Principal Investigators

  • radwa ELsherif, PHD · MUST

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-10
Primary Completion
2023-07-27
Completion
2023-07-27

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06072716 on ClinicalTrials.gov